An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Clinical trial NCT03154437 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03154437
- Sponsor
- Genentech, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.